What are the recommended guidelines for prescribing chronic pain medication, including opioid therapy, to patients in Tennessee (TN)?

Chronic Pain Medication Prescribing Guidelines for Tennessee

In Tennessee, clinicians prescribing chronic pain medications, particularly opioids, must follow both the CDC national guidelines and Tennessee-specific regulations, including the Tennessee Nonresidential Buprenorphine Treatment Guidelines effective January 1,2018, which are enforceable by the state medical and pharmacy boards. 1

Tennessee-Specific Requirements

Tennessee has established a unique regulatory framework that goes beyond federal recommendations:

• State-enforced practice standards: Tennessee legislation created enforceable guidelines through a multidisciplinary committee (physicians, pharmacists, lawyers, law enforcement, state officials) that define the standard of care for all buprenorphine prescribers, not just licensed office-based opioid treatment (OBOT) clinics 1

• Board enforcement: The Tennessee Board of Medical Examiners, Board of Osteopathic Examination, and Board of Pharmacy adopted these guidelines as official policy, giving them authority to discipline physicians who practice outside the standard of care 1

• Prescription Drug Monitoring Program (PDMP): Tennessee requires checking PDMP data as a risk mitigation strategy before prescribing opioids 2

Core Prescribing Framework

When NOT to Prescribe Opioids

Opioids should not be prescribed for headaches or fibromyalgia, as expected benefits are unlikely to outweigh risks regardless of previous therapies tried 2. This is a critical contraindication often overlooked in practice.

First-Line Treatment Approach

Nonpharmacologic therapy (exercise, cognitive behavioral therapy) and nonopioid medications (NSAIDs, acetaminophen, anticonvulsants, SNRIs) are preferred and must be maximized before considering opioids 2.

Key point: Patients do NOT need to sequentially "fail" these therapies before opioids can be considered. Rather, the clinical context determines whether expected benefits outweigh risks 2.

Exceptions Where Opioids May Be Appropriate

Opioids may be considered without exhausting other options when:

• Active cancer, palliative care, or end-of-life care
• Serious illness with poor prognosis for functional recovery
• Contraindications to other therapies exist
• Clinician and patient agree the overriding goal is comfort 2

Initiating Opioid Therapy: Required Steps

1. Establish Treatment Goals Before Prescribing

Before writing the first prescription, establish realistic goals for BOTH pain reduction AND functional improvement, and document how therapy will be discontinued if benefits don't outweigh risks 2.

• Use the 3-item PEG Assessment Scale to track outcomes: Pain average, interference with Enjoyment of life, interference with General activity 2
• Define "clinically meaningful improvement" as 30% improvement in BOTH pain and function scores 2
• Screen for depression, anxiety, and psychological comorbidities using validated instruments, as these interfere with pain resolution and must be optimized 2

2. Mandatory Patient Discussion

Before initiating opioids, discuss specific risks including fatal respiratory depression, lifelong opioid use disorder potential, constipation, tolerance, physical dependence, and withdrawal symptoms 2. Document this conversation.

Critical warnings to provide:

• Complete pain relief is unlikely; function improvement is the primary goal 2
• Overdose risk increases at higher doses 2
• Fatal overdose risk with concurrent benzodiazepines, alcohol, or other sedatives 2
• Impaired ability to operate vehicles, especially when initiating or increasing doses 2
• Secure storage requirements and disposal options to prevent household member access 2

3. Risk Assessment Requirements

Check the Tennessee PDMP and conduct urine drug testing before prescribing to identify risky behaviors and reduce doctor shopping 2.

High-risk factors requiring extra caution:

• Sleep-disordered breathing
• Reduced renal or hepatic function
• Older age (≥65 years)
• Pregnancy
• Mental health comorbidities
• History of substance use disorder
• Concurrent benzodiazepine use 2

Dosing Limits and Safety Thresholds

Mortality risk increases significantly above 50 MME (morphine milligram equivalents) per day, with dramatic escalation above 100 MME/day 2.

Specific risk data:

• 50-100 MME/day: 1.9 to 4.6-fold increased overdose risk; 0.15% absolute risk of fatal overdose 2
• ≥100 MME/day: 2.0 to 8.9-fold increased overdose risk; 0.25% absolute risk of fatal overdose and 4.04% risk of any overdose 2
• ≥200 MME/day: Mortality continues increasing, though more gradually 2

Methadone carries disproportionate overdose death risk and requires specialized prescribing knowledge 2.

Ongoing Management Requirements

Continuation Criteria

Continue opioids ONLY if there is clinically meaningful improvement (30% improvement in both pain AND function) that outweighs safety risks 2.

Monitoring Protocol

• Periodic reassessment of pain and function using validated instruments
• Repeat PDMP checks
• Ongoing urine drug testing 2
• Assessment for aberrant behaviors or medication misuse

Naloxone Co-Prescribing

Consider co-prescribing naloxone for overdose reversal, particularly at higher doses or with risk factors 2.

Common Pitfalls to Avoid

1. Prescribing opioids for headaches or fibromyalgia: These conditions have poor benefit-to-risk ratios with opioids 2

2. Combining opioids with benzodiazepines: This combination dramatically increases fatal overdose risk 2

3. Failing to establish functional goals: Pain reduction alone is insufficient; functional improvement must be documented 2

4. Ignoring cognitive limitations in elderly patients: Assess whether patients can safely manage opioid therapy 2

5. Not checking PDMP before prescribing: This is both a CDC recommendation and Tennessee requirement 2, 1

Tennessee Enforcement Context

Unlike many states that rely solely on CDC recommendations, Tennessee has made its guidelines enforceable through professional licensing boards, meaning prescribing outside these standards can result in disciplinary action 1. This creates a higher standard of accountability for Tennessee prescribers and emphasizes the state's commitment to quality addiction treatment and appropriate opioid prescribing practices.